Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy

Biochemical and Biophysical Research Communications

Volumn 351, Issue 4, 2006, Pages 896-902

  Theis, Jeanne L ^a   Martijn Bos, J ^b   Bartleson, Virginia B ^c   Will, Melissa L ^a   Binder, Josepha ^b   Vatta, Matteo ^d   Towbin, Jeffrey A ^d   Gersh, Bernard J ^b,c   Ommen, Steve R ^b,c   Ackerman, Michael J ^a,b,c  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Cardiomyopathy; Echocardiography; Genes; Hypertrophy; Septum; Z disc

Indexed keywords

ALPHA ACTININ; BINDING PROTEIN; CELL PROTEIN; FATTY ACID BINDING PROTEIN; LIM PROTEIN; MUSCLE PROTEIN; VINCULIN;

ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENOTYPE; HEART VENTRICLE SEPTUM; HEREDITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; MUTATIONAL ANALYSIS; MYOFILAMENT; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; ALLELES; CARDIOMYOPATHY, HYPERTROPHIC; DNA MUTATIONAL ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART SEPTUM; HUMANS; MALE; MICROFILAMENT PROTEINS; MICROFILAMENTS; MIDDLE AGED; MUTATION;

EID: 33750816260     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.10.119     Document Type: Article

References (33)

1. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
2. Geisterfer-Lowrance A.A., Kass S., Tanigawa G., Vosberg H., McKenna W., Seidman C.E., and Seidman J.G. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62 (1990) 999-1006
3. Lever H.M., Karam R.F., Currie P.J., and Healy B.P. Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape. Circulation 79 (1989) 580-589
4. Solomon S.D., Wolff S., Watkins H., Ridker P.M., Come P., McKenna W.J., Seidman C.E., and Lee R.T. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J. Am. Coll. Cardiol. 22 (1993) 498-505
5. Binder J., Ommen S.R., Gersh B.J., Van Driest S.L., Tajik A.J., Nishimura R.A., and Ackerman M.J. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clin. Proc. 81 (2006) 459-467
6. Van Driest S.L., Jaeger M.A., Ommen S.R., Will M.L., Gersh B.J., Tajik A.J., and Ackerman M.J. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 602-610
7. Van Driest S.L., Vasile V.C., Ommen S.R., Will M.L., Gersh B.J., Nishimura R.A., Tajik A.J., and Ackerman M.J. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 1903-1910
8. Van Driest S.L., Ellsworth E.G., Ommen S.R., Tajik A.J., Gersh B.J., and Ackerman M.J. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation 108 (2003) 445-451
9. Bos J.M., Poley R.N., Ny M., Tester D.J., Xu X., Vatta M., Towbin J.A., Gersh B.J., Ommen S.R., and Ackerman M.J. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Mol. Genet. Metab. 88 (2006) 78-85
10. Vasile V.C., Will M.L., Ommen S.R., Edwards W.D., Olson T.M., and Ackerman M.J. Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy. Mol. Genet. Metab. 87 (2006) 169-174
11. Hayashi T., Arimura T., Itoh-Satoh M., Ueda K., Hohda S., Inagaki N., Takahashi M., Hori H., Yasunami M., Nishi H., Koga Y., Nakamura H., Matsuzaki M., Choi B.Y., Bae S.W., You C.W., Han K.H., Park J.E., Knoll R., Hoshijima M., Chien K.R., and Kimura A. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 2192-2201
12. Geier C., Perrot A., Ozcelik C., Binner P., Counsell D., Hoffmann K., Pilz B., Martiniak Y., Gehmlich K., van der Ven P.F., Furst D.O., Vornwald A., von Hodenberg E., Nurnberg P., Scheffold T., Dietz R., and Osterziel K.J. Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation 107 (2003) 1390-1395
13. Vasile V.C., Ommen S.R., Edwards W.D., and Ackerman M.J. A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy. Biochem. Biophys. Res. Comm. 345 (2006) 998-1003
14. Mohapatra B., Jimenez S., Lin J.H., Bowles K.R., Coveler K.J., Marx J.G., Chrisco M.A., Murphy R.T., Lurie P.R., Schwartz R.J., Elliott P.M., Vatta M., McKenna W., Towbin J.A., and Bowles N.E. Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol. Genet. Metab. 80 (2003) 207-215
15. Olson T.M., Illenberger S., Kishimoto N.Y., Huttelmaier S., Keating M.T., and Jockusch B.M. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 105 (2002) 431-437
16. Kamisago M., Sharma S.D., DePalma S.R., Solomon S., Sharma P., McDonough B., Smoot L., Mullen M.P., Woolf P.K., Wigle E.D., Seidman J.G., and Seidman C.E. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N. Engl. J. Med. 343 (2000) 1688-1696
17. Olson T.M., Doan T.P., Kishimoto N.Y., Whitby F.G., Ackerman M.J., and Fananapazir L. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 32 (2000) 1687-1694
18. Olson T.M., Kishimoto N.Y., Whitby F.G., and Michels V.V. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J. Mol. Cell. Cardiol. 33 (2001) 723-732
19. Gerull B., Gramlich M., Atherton J., McNabb M., Trombitas K., Sasse-Klaassen S., Seidman J.G., Seidman C., Granzier H., Labeit S., Frenneaux M., and Thierfelder L. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat. Genet. 30 (2002) 201-204
20. Daehmlow S., Erdmann J., Knueppel T., Gille C., Froemmel C., Hummel M., Hetzer R., and Regitz-Zagrosek V. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 298 (2002) 116-120
21. Vatta M., Mohapatra B., Jimenez S., Sanchez X., Faulkner G., Perles Z., Sinagra G., Lin J.H., Vu T.M., Zhou Q., Bowles K.R., Di Lenarda A., Schimmenti L., Fox M., Chrisco M.A., Murphy R.T., McKenna W., Elliott P., Bowles N.E., Chen J., Valle G., and Towbin J.A. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J. Am. Coll. Cardiol. 42 (2003) 2014-2027
22. Zhou Q., Chu P.H., Huang C., Cheng C.F., Martone M.E., Knoll G., Shelton G.D., Evans S., and Chen J. Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J. Cell Biol. 155 (2001) 605-612
23. Frank D., Kuhn C., Katus H.A., and Frey N. The sarcomeric Z-disc: a nodal point in signalling and disease. J. Mol. Med. (2006) 1-23
24. Pyle W.G., and Solaro R.J. At the crossroads of myocardial signaling: the role of Z-discs in intracellular signaling and cardiac function. Circ. Res. 94 (2004) 296-305
25. Knoll R., Hoshijima M., Hoffman H.M., Person V., Lorenzen-Schmidt I., Bang M.L., Hayashi T., Shiga N., Yasukawa H., Schaper W., McKenna W., Yokoyama M., Schork N.J., Omens J.H., McCulloch A.D., Kimura A., Gregorio C.C., Poller W., Schaper J., Schultheiss H.P., and Chien K.R. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111 (2002) 943-955
26. Van Driest S.L., Ommen S.R., Tajik A.J., Gersh B.J., and Ackerman M.J. Yield of genetic testing in hypertrophic cardiomyopathy. Mayo Clin. Proc. 80 (2005) 739-744
27. Blair E., Redwood C., Ashrafian H., Oliveira M., Broxholme J., Kerr B., Salmon A., Ostman-Smith I., and Watkins H. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum. Mol. Genet. 10 (2001) 1215-1220
28. Arad M., Maron B.J., Gorham J.M., Johnson Jr. W.H., Saul J.P., Perez-Atayde A.R., Spirito P., Wright G.B., Kanter R.J., Seidman C.E., and Seidman J.G. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N. Engl. J. Med. 352 (2005) 362-372
29. Frey N., Katus H.A., Olson E.N., and Hill J.A. Hypertrophy of the heart: a new therapeutic target?. Circulation 109 (2004) 1580-1589
30. Perkins M.J., Van Driest S.L., Ellsworth E.G., Will M.L., Gersh B.J., Ommen S.R., and Ackerman M.J. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy. Eur. Heart J. 26 (2005) 2457-2462
31. Xia H., Winokur S.T., Kuo W.L., Altherr M.R., and Bredt D.S. Actinin-associated LIM protein: identification of a domain interaction between PDZ and spectrin-like repeat motifs. J. Cell Biol. 139 (1997) 507-515
32. Papa I., Astier C., Kwiatek O., Raynaud F., Bonnal C., Lebart M.C., Roustan C., and Benyamin Y. Alpha actinin-CapZ, an anchoring complex for thin filaments in Z-line. J. Muscle Res. Cell Motil. 20 (1999) 187-197
33. Tsoporis J.N., Marks A., Kahn H.J., Butany J.W., Liu P.P., O'Hanlon D., and Parker T.G. Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice. J. Clin. Invest. 102 (1998) 1609-1616